KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 122 filers reported holding KURA ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -97.9% | 215 | -95.2% | 0.00% | – |
| Q2 2023 | $47 | -100.0% | 4,443 | -12.4% | 0.00% | – |
| Q3 2021 | $110,000 | -20.9% | 5,070 | -24.0% | 0.00% | – |
| Q2 2021 | $139,000 | +82.9% | 6,667 | +147.1% | 0.00% | – |
| Q1 2021 | $76,000 | -86.9% | 2,698 | -84.8% | 0.00% | -100.0% |
| Q4 2020 | $579,000 | +106.0% | 17,746 | +2.7% | 0.00% | – |
| Q2 2020 | $281,000 | +751.5% | 17,287 | +417.1% | 0.00% | – |
| Q1 2020 | $33,000 | +175.0% | 3,343 | +260.6% | 0.00% | – |
| Q4 2019 | $12,000 | +200.0% | 927 | +247.2% | 0.00% | – |
| Q1 2019 | $4,000 | -97.3% | 267 | -97.5% | 0.00% | – |
| Q4 2018 | $148,000 | +85.0% | 10,598 | +130.9% | 0.00% | – |
| Q3 2018 | $80,000 | +233.3% | 4,590 | +245.1% | 0.00% | – |
| Q2 2018 | $24,000 | – | 1,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |